Interleukin 28B Polymorphism Predicts Treatment Outcome Among Egyptian Patients Infected With HCV Genotype 4. [electronic resource]
Producer: 20160421Description: 947-50 p. digitalISSN:- 0172-6390
- Adult
- Alleles
- Antiviral Agents
- Egypt
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferons -- therapeutic use
- Interleukins -- genetics
- Logistic Models
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Polymorphism, Single Nucleotide
- Prognosis
- RNA, Viral -- blood
- Real-Time Polymerase Chain Reaction
- Ribavirin -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.